ScienceMed®

Eficácia de uma intervenção de autogestão baseada em inteligência artificial para apoiar indivíduos com doenças musculoesqueléticas na Noruega: fundamentação e protocolo para o ensaio controlado randomizado SmaRTWork

Ortopedia
Imagem de arquivo, ilustrativa — não é do estudo. Feixes de músculo esquelético em cortes longitudinal e transversal, ao microscópio óptico. Berkshire Community College Bioscience Image Library · CC0 · Wikimedia Commons

Ensaio clínico randomizadoNível 2 · Nova evidênciaBMJ open18 ago 20260 citações

Salvar

Resumo original em inglês

O que aconteceu

Long-term sickness absence represents a major public health challenge with far-reaching consequences for both individuals and society. Musculoskeletal disorders (MSDs) are among the leading causes of sickness absence. Although mobile apps show promise for supporting self-management of MSDs, high-quality evidence remains limited, and outcomes related to work participation are rarely examined. This trial aims to evaluate whether an individually tailored, app-based self-management intervention (SmaRTWork), provided in addition to usual care, improves return-to-work compared with usual care alone among individuals on sick leave due to MSDs.

We will conduct a randomised controlled trial with two parallel arms: 1) SmaRTWork in addition to usual care and 2) usual care alone. Individuals 20-59 years old who have been sick-listed for <12 weeks due to back, neck or widespread pain will be recruited through clinicians in primary health care. Eligible participants are randomised 1:1 to one of the two arms. We aim to include 298 participants, 149 in each arm. The primary outcome is time to sustainable return-to-work, defined as one consecutive month without receiving medical benefits, assessed over a 12-month period using registry data. Secondary outcomes include health-related measures assessed at baseline, 3, 6 and 12 months. The trial will also incorporate qualitative studies, a process evaluation and a health economic evaluation.

The trial is approved by the Committees for Clinical Trials of Pharmaceuticals and Medical Devices (Ref. 563919). Results will be published in peer-reviewed journals and presented at national and international conferences.

O que encontraram

NCT07034040.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Effectiveness of an artificial intelligence-based self-management intervention to support sick-listed individuals with musculoskeletal disorders in Norway: rationale and protocol for the SmaRTWork randomised controlled trial

Lene Aasdahl, Kerstin Bach, Tom Ivar Lund Nilsen, Stuart Gallina Ottersen, Nina E Klevanger, Christoph Eder, Cecilie Krage Øverås, Fredrik Granviken, Julia Debik, Lars Christian Naterstad Lervik et al.

Descritores MeSH

  • Self-Management
  • Musculoskeletal Diseases
  • Sick Leave
  • Return to Work
  • Mobile Applications
  • Young Adult
  • Norway
  • Research Design
  • Adult
  • Female

Veja também